960 related articles for article (PubMed ID: 25730668)
1. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.
Winkler EA; Nishida Y; Sagare AP; Rege SV; Bell RD; Perlmutter D; Sengillo JD; Hillman S; Kong P; Nelson AR; Sullivan JS; Zhao Z; Meiselman HJ; Wendy RB; Soto J; Abel ED; Makshanoff J; Zuniga E; De Vivo DC; Zlokovic BV
Nat Neurosci; 2015 Apr; 18(4):521-530. PubMed ID: 25730668
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology.
Cao Y; Xu H; Zhu Y; Shi MJ; Wei L; Zhang J; Cheng S; Shi Y; Tong H; Kang L; Lu L; Luo H; Yang X; Bai X; Wang R; Ma Y; Wang Y; Wang Z; Zhong K; Zhao BQ; Fan W
PLoS Biol; 2019 Jun; 17(6):e3000313. PubMed ID: 31185010
[TBL] [Abstract][Full Text] [Related]
3. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.
Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM
Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
5. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
Sagare AP; Bell RD; Zlokovic BV
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
[TBL] [Abstract][Full Text] [Related]
8. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
9. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
[TBL] [Abstract][Full Text] [Related]
11. Sugar and Alzheimer's disease: a bittersweet truth.
Iadecola C
Nat Neurosci; 2015 Apr; 18(4):477-8. PubMed ID: 25811474
[TBL] [Abstract][Full Text] [Related]
12. Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.
Boyanova ST; Lloyd-Morris E; Corpe C; Rahman KM; Farag DB; Page LK; Wang H; Fleckney AL; Gatt A; Troakes C; Vizcay-Barrena G; Fleck R; Reeves SJ; Thomas SA
PLoS One; 2023; 18(10):e0286278. PubMed ID: 37874822
[TBL] [Abstract][Full Text] [Related]
13. Modifications of physical and functional integrity of the blood-brain barrier in an inducible mouse model of neurodegeneration.
Taccola C; Barneoud P; Cartot-Cotton S; Valente D; Schussler N; Saubaméa B; Chasseigneaux S; Cochois V; Mignon V; Curis E; Lochus M; Nicolic S; Dodacki A; Cisternino S; Declèves X; Bourasset F
Neuropharmacology; 2021 Jun; 191():108588. PubMed ID: 33940010
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
15. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
16. Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation.
ElAli A; Thériault P; Préfontaine P; Rivest S
Acta Neuropathol Commun; 2013 Nov; 1():75. PubMed ID: 24252187
[TBL] [Abstract][Full Text] [Related]
17. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
[TBL] [Abstract][Full Text] [Related]
18. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
Hartz AM; Miller DS; Bauer B
Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
[TBL] [Abstract][Full Text] [Related]
19. The blood brain barrier in Alzheimer's disease.
Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
[TBL] [Abstract][Full Text] [Related]
20. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
